Results: 1-6 |
Results: 6

Authors: Arase, Y Chayama, K Ikeda, K Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Suzuki, F Akuta, N Someya, T Kobayashi, M Kumada, H
Citation: Y. Arase et al., Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C, HEPATOL RES, 21(1), 2001, pp. 55-66

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen, J GASTRO, 36(4), 2001, pp. 242-247

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Pathogenic significance and organic virus levels in patients infected withTT virus, INTERVIROLO, 44(5), 2001, pp. 291-297

Authors: Chayama, K Suzuki, F Tsubota, A Akuta, N Someya, T Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Ikeda, K Kumada, H
Citation: K. Chayama et al., Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype, J VIROL MET, 95(1-2), 2001, pp. 33-45

Authors: Akuta, N Chayama, K Suzuki, F Someya, T Kobayashi, M Tsubota, A Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: N. Akuta et al., Risk factors of hepatitis C virus-related liver cirrhosis in young adults:Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2)0201 allele, J MED VIROL, 64(2), 2001, pp. 109-116

Authors: Kobayashi, M Ikeda, K Akuta, N Someya, T Suzuki, F Tsubota, A Suzuki, Y Saitoh, S Arase, Y Chayama, K Kumada, H
Citation: M. Kobayashi et al., Relationship between five-year histological outcome and serial changes in serum alanine aminotransferase in patients with biochemical and virologicalrelapse after interferon treatment for chronic hepatitis C, INTERVIROLO, 43(3), 2000, pp. 174-179
Risultati: 1-6 |